STEFANINI, Giulio Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 9.029
AS - Asia 6.691
EU - Europa 1.858
SA - Sud America 1.529
AF - Africa 293
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.423
Nazione #
US - Stati Uniti d'America 8.823
SG - Singapore 4.158
BR - Brasile 1.282
CN - Cina 1.112
VN - Vietnam 635
FI - Finlandia 375
IE - Irlanda 277
IT - Italia 218
DE - Germania 214
NG - Nigeria 177
IN - India 164
HK - Hong Kong 160
FR - Francia 142
GB - Regno Unito 130
SE - Svezia 119
NL - Olanda 101
AR - Argentina 97
CA - Canada 85
BD - Bangladesh 72
MX - Messico 64
RU - Federazione Russa 55
TR - Turchia 52
IQ - Iraq 50
EC - Ecuador 40
ID - Indonesia 39
PL - Polonia 37
ES - Italia 33
JP - Giappone 31
UA - Ucraina 28
VE - Venezuela 28
ZA - Sudafrica 28
MA - Marocco 23
SA - Arabia Saudita 22
BE - Belgio 21
PK - Pakistan 20
CO - Colombia 19
PE - Perù 18
IL - Israele 17
PH - Filippine 17
CL - Cile 16
PY - Paraguay 16
MY - Malesia 15
UZ - Uzbekistan 15
DZ - Algeria 14
JM - Giamaica 14
AZ - Azerbaigian 13
GR - Grecia 13
KE - Kenya 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
JO - Giordania 11
LT - Lituania 11
AT - Austria 10
PT - Portogallo 10
CZ - Repubblica Ceca 9
EG - Egitto 9
UY - Uruguay 9
CR - Costa Rica 8
NP - Nepal 8
RO - Romania 8
KZ - Kazakistan 7
TH - Thailandia 7
TW - Taiwan 7
CH - Svizzera 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
GT - Guatemala 5
KW - Kuwait 5
LB - Libano 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BO - Bolivia 4
HN - Honduras 4
IR - Iran 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BA - Bosnia-Erzegovina 3
CU - Cuba 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
NO - Norvegia 3
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
GE - Georgia 2
KH - Cambogia 2
Totale 19.386
Città #
Singapore 1.912
Chandler 980
Wilmington 956
Ashburn 862
San Jose 731
The Dalles 608
Shanghai 525
Dallas 513
San Mateo 417
Helsinki 373
Boardman 272
Dublin 271
Beijing 269
New York 248
Ho Chi Minh City 229
Ann Arbor 228
Lawrence 181
Princeton 181
Benin City 177
Hanoi 160
Leawood 147
Hong Kong 143
Los Angeles 119
São Paulo 117
Woodbridge 98
Paris 95
Fairfield 90
Amsterdam 86
Pune 57
Santa Clara 56
Milan 54
Seattle 46
London 40
Munich 36
Falkenstein 34
Warsaw 34
Phoenix 32
Brasília 29
Chicago 29
Orem 29
Rio de Janeiro 29
Belo Horizonte 28
Montreal 28
Da Nang 27
Council Bluffs 26
Chennai 25
Curitiba 25
Buffalo 24
Kocaeli 24
Tokyo 23
Brooklyn 22
Mexico City 22
Toronto 21
Brussels 20
Haiphong 20
Norwalk 20
San Diego 20
Stockholm 20
Baghdad 19
San Francisco 19
Campinas 16
Cologno Monzese 16
Dhaka 16
Reston 16
Ribeirão Preto 16
Frankfurt am Main 15
Guarulhos 15
Assago 14
Guayaquil 14
Quito 14
Denver 13
Atlanta 12
Boston 12
Fortaleza 12
Johannesburg 12
Manchester 12
Moscow 12
Naples 12
Porto Alegre 12
Redmond 12
Baku 11
Houston 11
Hải Dương 11
Kingston 11
Nairobi 11
New Delhi 11
Tashkent 11
Abbiategrasso 10
Buenos Aires 10
Charlotte 10
Kuala Lumpur 10
Redwood City 10
Amman 9
Caxias do Sul 9
Goiânia 9
Guangzhou 9
Lima 9
Asunción 8
Athens 8
Columbus 8
Totale 12.395
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 140
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 136
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. 118
2014 ESC/EACTS Guidelines on myocardial revascularization 115
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 112
CAD in TAVI patients: relevance of disease complexity 109
2014 ESC/EACTS Guidelines on myocardial revascularization. 109
2018 ESC/EACTS Guidelines on myocardial revascularization 109
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 109
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 107
2014 ESC/EACTS Guidelines on myocardial revascularization 106
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 105
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial. 105
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 105
Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. 105
2018 ESC/EACTS Guidelines on myocardial revascularization. 102
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 101
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 100
What constitutes sufficient clinical evidence for stents? SpotLITE on the evaluation of novel coronary devices. 98
A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug 98
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 97
2018 ESC/EACTS Guidelines on myocardial revascularization 97
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 97
Does clinical data quality affect fluid-structure interaction simulations of patient-specific stenotic aortic valve models? 96
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 96
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 95
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. 95
[Towards a standardized and minimalist future in interventional cardiology] 93
[Advances in the treatment of complex atherosclerotic disease: cracking the calcium and beyond] 93
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach 93
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 92
An update on drug-eluting stents versus bare-metal stents in PCI treatment: are there any remaining indications for BMS use? 92
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 91
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. 91
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. 90
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 88
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 88
Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. 88
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 88
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom (TM) drug-coated stent vs. the Gazelle (TM) bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy 88
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 87
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis 86
Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients 86
Coronary stents: novel developments 85
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 85
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 85
Another reason to endorse and spread guidelines 85
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review 84
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 84
[SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention] 83
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 83
The synergy stent in high-bleeding risk patients: why design matters 83
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study 83
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 83
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 83
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 82
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 82
New approach to direct stenting using a novel 'All-In-One' coronary stent system via 5 french diagnostic catheters: A pilot study 81
Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 80
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 79
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 79
Characterization of Myocardial Injury in Patients With COVID-19 79
What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization? 78
Can Coronary Computed Tomography Angiography Replace Invasive Angiography? Coronary Computed Tomography Angiography Cannot Replace Invasive Angiography 78
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. 78
Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents A Meta-Analysis 77
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 77
Stent performance: never too late to sort it out. 77
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 77
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. 76
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. 76
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials 75
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes 75
State of the art: coronary artery stents - past, present and future. 75
[Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times] 74
Management of ST-elevation myocardial infarction according to European and American guidelines. 74
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis 74
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 73
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 73
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry 73
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention Results of a Nonrandomized Observational Study 73
Predictors of Adverse Events Among Patient Undergoing Primary Percutaneous Coronary Intervention - Insights From a Pooled Analysis of the COMFORTABLE-AMI and EXAMINATION trials 73
Severe aortic stenosis and coronary artery disease. 73
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 73
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. 73
The Valsalva maneuver in the diagnosis of patent foramen ovale. 72
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. 72
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. 72
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial 72
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 72
Myocardial revascularization appropriateness in Italy: Measuring the unmeasured 71
Are the culprit lesions severely stenotic? 71
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 71
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 70
Myocardial ischemia and coronary disease in heart failure. 70
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. 70
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. 70
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial 70
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration 70
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group 70
Totale 8.652
Categoria #
all - tutte 128.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 0 0 0 0 0 0 0 186
2021/2022902 24 9 16 245 6 2 21 148 73 68 246 44
2022/20232.885 421 110 236 313 315 206 13 213 514 287 197 60
2023/20242.132 222 151 406 128 105 275 153 128 20 49 196 299
2024/20253.368 45 32 43 32 60 351 281 330 478 837 416 463
2025/20268.720 1.377 683 500 871 313 460 2.541 473 465 581 314 142
Totale 19.823